High-level production of l-homoserine using a non-induced, non-auxotrophic Escherichia coli chassis through metabolic engineering

Yu Zhang,Minhua Wei,Guihong Zhao,Wenjie Zhang,Yingzi Li,Beibei Lin,Yanjun Li,Qingyang Xu,Ning Chen,Chenglin Zhang
DOI: https://doi.org/10.1016/j.biortech.2021.124814
IF: 11.4
2021-05-01
Bioresource Technology
Abstract:<p>L-Homoserine is a valuable non-proteinogenic amino acid used in the synthesis of various important compounds. Microbial fermentation has potential value for producing L-homoserine on a large scale, but suffers from a low yield and the need for expensive additives. In this study, a non-induced, non-auxotrophic, plasmid-free <em>Escherichia coli</em> chassis for the high-efficiency production of L-homoserine was constructed. Initially, the L-homoserine degradation pathway was dynamically attenuated. Subsequently, systems metabolic engineering strategies were employed, including reinforcing the synthetic flux, improving NADPH generation, and elevating L-homoserine efflux. The constructed strain HOM-14, produced 60.1 g/L L-homoserine without additional supplements or inducers, which achieved the highest fermentative production efficiency of L-homoserine till date. Moreover, common byproducts, such as acetate, did not accumulate. The strategies presented here can be applied in the further engineering of chassis for the scale-up production of L-homoserine and derivatives.</p>
energy & fuels,biotechnology & applied microbiology,agricultural engineering
What problem does this paper attempt to address?